
Laura Lynne Stockton
Examiner (ID: 114, Phone: (571)272-0710 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1646, 1626, 1201, 1614, 2899, 1613 |
| Total Applications | 3245 |
| Issued Applications | 2194 |
| Pending Applications | 342 |
| Abandoned Applications | 753 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19916157
[patent_doc_number] => 12291510
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-06
[patent_title] => 2,5-dimercapto-1,3,4-thiadiazole (DMTD) derivatives
[patent_app_type] => utility
[patent_app_number] => 17/760830
[patent_app_country] => US
[patent_app_date] => 2020-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6574
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17760830
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/760830 | 2,5-dimercapto-1,3,4-thiadiazole (DMTD) derivatives | Sep 15, 2020 | Issued |
Array
(
[id] => 17982554
[patent_doc_number] => 20220348590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => CYCLOOXYGENASE-2 INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/642662
[patent_app_country] => US
[patent_app_date] => 2020-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74461
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17642662
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/642662 | CYCLOOXYGENASE-2 INHIBITORS AND USES THEREOF | Sep 9, 2020 | Pending |
Array
(
[id] => 16621391
[patent_doc_number] => 20210040044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR
[patent_app_type] => utility
[patent_app_number] => 17/006193
[patent_app_country] => US
[patent_app_date] => 2020-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51082
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17006193
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/006193 | COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR | Aug 27, 2020 | Abandoned |
Array
(
[id] => 17882708
[patent_doc_number] => 20220298185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => Nucleoside Prodrugs and Uses Related Thereto
[patent_app_type] => utility
[patent_app_number] => 17/637365
[patent_app_country] => US
[patent_app_date] => 2020-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42516
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17637365
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/637365 | Nucleoside prodrugs and uses related thereto | Aug 23, 2020 | Issued |
Array
(
[id] => 17867245
[patent_doc_number] => 20220289981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => PIGMENTED AND FLUORESCENT COMPOUNDS DERIVED FROM THE ADDITION OF A PRIMARY OR SECONDARY AMINE TO AN ALDEHYDE
[patent_app_type] => utility
[patent_app_number] => 17/636729
[patent_app_country] => US
[patent_app_date] => 2020-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9620
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17636729
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/636729 | PIGMENTED AND FLUORESCENT COMPOUNDS DERIVED FROM THE ADDITION OF A PRIMARY OR SECONDARY AMINE TO AN ALDEHYDE | Aug 20, 2020 | Pending |
Array
(
[id] => 18004923
[patent_doc_number] => 20220363689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => INHIBITOR OF BTK AND MUTANTS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/764329
[patent_app_country] => US
[patent_app_date] => 2020-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 114943
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 449
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17764329
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/764329 | INHIBITOR OF BTK AND MUTANTS THEREOF | Aug 19, 2020 | Pending |
Array
(
[id] => 16482354
[patent_doc_number] => 20200375954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => THERAPEUTIC AGENT FOR FOOD COMPETENCE DISORDER IN STOMACH
[patent_app_type] => utility
[patent_app_number] => 16/998637
[patent_app_country] => US
[patent_app_date] => 2020-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2269
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16998637
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/998637 | THERAPEUTIC AGENT FOR FOOD COMPETENCE DISORDER IN STOMACH | Aug 19, 2020 | Abandoned |
Array
(
[id] => 17913133
[patent_doc_number] => 20220315528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => INHIBITORS OF PHOSPHOLIPID SYNTHESIS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/635891
[patent_app_country] => US
[patent_app_date] => 2020-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33077
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17635891
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/635891 | INHIBITORS OF PHOSPHOLIPID SYNTHESIS AND METHODS OF USE | Aug 19, 2020 | Pending |
Array
(
[id] => 17214409
[patent_doc_number] => 20210347746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => PROCESS FOR PREPARING 1,1,3-TRIOXO-1,2-BENZOTHIAZOLE-6-CARBOXAMIDE
[patent_app_type] => utility
[patent_app_number] => 16/994855
[patent_app_country] => US
[patent_app_date] => 2020-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4284
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16994855
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/994855 | Process for preparing 1,1,3-trioxo-1,2-benzothiazole-6-carboxamide | Aug 16, 2020 | Issued |
Array
(
[id] => 17866962
[patent_doc_number] => 20220289697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => Reduction of the odor of monothiocarbonate compounds by addition of oxidants
[patent_app_type] => utility
[patent_app_number] => 17/634313
[patent_app_country] => US
[patent_app_date] => 2020-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2607
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17634313
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/634313 | Reduction of the odor of monothiocarbonate compounds by addition of oxidants | Aug 12, 2020 | Issued |
Array
(
[id] => 17807405
[patent_doc_number] => 20220259240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => PROCESS FOR THE PREPARATION OF RUTHENIUM COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 17/594899
[patent_app_country] => US
[patent_app_date] => 2020-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9128
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594899
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/594899 | PROCESS FOR THE PREPARATION OF RUTHENIUM COMPLEXES | Aug 12, 2020 | Abandoned |
Array
(
[id] => 17742531
[patent_doc_number] => 11390588
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => 2-substituted amino-naphth (1,2-d) imidazol-5-one compounds of pharmaceutically acceptable salts thereof
[patent_app_type] => utility
[patent_app_number] => 16/989582
[patent_app_country] => US
[patent_app_date] => 2020-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21832
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16989582
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/989582 | 2-substituted amino-naphth (1,2-d) imidazol-5-one compounds of pharmaceutically acceptable salts thereof | Aug 9, 2020 | Issued |
Array
(
[id] => 16570522
[patent_doc_number] => 20210009528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR
[patent_app_type] => utility
[patent_app_number] => 16/938864
[patent_app_country] => US
[patent_app_date] => 2020-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50745
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16938864
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/938864 | Compounds and methods for the targeted degradation of androgen receptor | Jul 23, 2020 | Issued |
Array
(
[id] => 17784640
[patent_doc_number] => 11407752
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-09
[patent_title] => Substituted 4,6-dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3'-indoline]-2',5(3H)-dione analogues
[patent_app_type] => utility
[patent_app_number] => 16/938886
[patent_app_country] => US
[patent_app_date] => 2020-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 18888
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16938886
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/938886 | Substituted 4,6-dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3'-indoline]-2',5(3H)-dione analogues | Jul 23, 2020 | Issued |
Array
(
[id] => 16570561
[patent_doc_number] => 20210009567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/936821
[patent_app_country] => US
[patent_app_date] => 2020-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12811
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16936821
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/936821 | HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS | Jul 22, 2020 | Abandoned |
Array
(
[id] => 18518466
[patent_doc_number] => 11708346
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Treatment and prevention of neuropathic pain with P2Y14 antagonists
[patent_app_type] => utility
[patent_app_number] => 16/936951
[patent_app_country] => US
[patent_app_date] => 2020-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 19
[patent_no_of_words] => 9553
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16936951
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/936951 | Treatment and prevention of neuropathic pain with P2Y14 antagonists | Jul 22, 2020 | Issued |
Array
(
[id] => 18733396
[patent_doc_number] => 11802119
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-31
[patent_title] => Method for producing cyclic disulfonic acid ester compound
[patent_app_type] => utility
[patent_app_number] => 17/629186
[patent_app_country] => US
[patent_app_date] => 2020-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3786
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17629186
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/629186 | Method for producing cyclic disulfonic acid ester compound | Jul 21, 2020 | Issued |
Array
(
[id] => 19536698
[patent_doc_number] => 12129239
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-29
[patent_title] => Method for producing methylene disulfonate compound
[patent_app_type] => utility
[patent_app_number] => 17/629167
[patent_app_country] => US
[patent_app_date] => 2020-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4065
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17629167
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/629167 | Method for producing methylene disulfonate compound | Jul 21, 2020 | Issued |
Array
(
[id] => 17990152
[patent_doc_number] => 20220356189
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => ANTIVIRAL HETEROCYCLIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/930622
[patent_app_country] => US
[patent_app_date] => 2020-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50054
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 431
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16930622
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/930622 | Antiviral heterocyclic compounds | Jul 15, 2020 | Issued |
Array
(
[id] => 18250323
[patent_doc_number] => 20230077362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => MOLECULES HAVING CERTAIN PESTICIDAL UTILITIES, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES RELATED THERETO
[patent_app_type] => utility
[patent_app_number] => 17/626865
[patent_app_country] => US
[patent_app_date] => 2020-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 181790
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17626865
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/626865 | MOLECULES HAVING CERTAIN PESTICIDAL UTILITIES, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES RELATED THERETO | Jul 15, 2020 | Pending |